Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Cardiovasc Revasc Med. 2020 May 1;21(11):1360–1368. doi: 10.1016/j.carrev.2020.04.030

Table 1.

Study design and characteristics of included studies.

Study Sample Inclusion criteria Primary outcomes Secondary outcome Length of stay Revascularization
&
antiplatelets
Follow up Risk ratio for early vs late discharge
Mortality Readmissions MACE
Observational studies
Swaminathan 2015 33,920
Short LOS (n = 9135)
Medium LOS (n = 15,704)
Long LOS (n = 9081)
≥65 age PPCI for STEMI 2004–2009 NCDR Database 30-day mortality or MACE defined as composite of mortality, MI readmissions, unplanned revascularizations 30-day all-cause mortality, readmissions for MI, unplanned revascularization, bleeding events Very short 1–2 days
Short≤3 days
Medium = 4–5 days
Long ≥5 days
Femoral access 97.9% ED, 98% LD ED ≤ 3 days
Events = 82
Total = 9135
Risk Ratio ED = 82/9135

LD > 3 days
Events = 475
Total = 24,785
Risk Ratio LD = 475/24785
ED ≤ 3 days
Events = 91
Total = 9135
Risk Ratio for ED: 91/9135

LD > 3 days
Events = 318
Total = 24,785
Risk Ratio LD: 318/24785
ED ≤ 3 days
Events = 174
Total = 9135
Risk Ratio ED: 174/9135

LD > 3 days
Events = 799 >
Total = 24,785
Risk Ratio LD: 799/24785
Karabulut 2011 267
D/C in 1-day (90)
D/C in 2 days (94)
D/C in 3-days (46)
D/C in >3 days (37)
PPCI for STEMI 1-year mortality or reinfarction or revascularization of infarct related artery. Defining an optimal LOS according to demographic and clinical characteristics 1-day
2-days
3-days
>3-days
Tirofiban 45.2% ED, 73% LD 1-year ED ≤ 3 days
Events = 1
Total = 230
Risk Ratio ED = 1/230

LD > 3 days
Events = 3
Total = 37
Risk Ratio LD = 3/37
ED ≤ 3 days
Events = 37
Total = 230
Risk Ratio ED = 37/230

LD > 3 days
Events = 11
Totals = 37
Risk Ratio LD = 11/37
Jones 2012 2779
D/C in 2- days (1117)
D/C in 3-days (620)
D/C in >3-days (916)
PPCI for STEMI 30-day readmissions MACE defined as composite of death, recurrent MI, revascularization, stroke, target vessel revascularization 2-days
3-days
>3-days
Radial access 42.5% ED, 31.2% LD
GP IIb/IIIa 90% ED, 87.6% LD
2.8 years (IQR 1.3–4.4) (median) ED ≤ 3 days
Events = 87
Total = 1737
Risk Ratio ED: 87/1737

LD > 3 days
Events = 42
Total = 916
Risk Ratio LD: 42/916
ED ≤ 3 days
Events = 160
Total = 1737
Risk Ratio ED: 160/1737

LD > 3 days
Events = 284
Total = 916
Risk Ratio LD: 284/916
Noman 2013 2448
ED (1542)
LD (906)
PPCI for STEMI Mortality at 1, 7 and 30 days Radial access 72.6% ED, 64.1% LD
Aspiration thrombectomy 45.7% ED, 39.3% LD
GP IIb/IIIa inhibitors 83.3% ED, 79.4% LD DES 59.5% ED, 53.6% LD
ED 584 days and 582 days in LD (mean) ED
Events = 11
Total = 1542
Risk Ratio ED: 11/1542

LD
Events = 15
Total = 906
Risk Ratio LD: 15/906
Randomized controlled clinical trials
Satilmisoglu 2016 (EDAP-PCI) 769
ED (370)
LD (363)
PPCI for STEMI within 12 h of onset, Uneventful 24 h f/u, Single epicardial vessel to be treated 30-day mortality Readmission at 30 days due to reinfarction, unstable angina, arrhythmia, CHF, revascularization, stroke, major bleeding. Functional status Health related QOL ED < 48 to 56 h. Aspirin
Clopidogrel
30-days ED < 48 h to 56 h.
Events = 2
Total = 370
Risk Ratio ED =2/370

LD > 48 h to 56 h.
Events = 3
Total = 363
Risk Ratio LD = 3/363
ED < 48 h to 56 h.
Events = 14
Total = 370
Risk Ratio ED = 14/370
LD > 48 h to 56 h.
Events = 25
Total = 363
Risk Ratio LD = 25/363
Melberg 2015 215
ED (107)
LD (108)
STEMI within 2 days of admission with Zwolle risk score ≤ 3 30-day mortality 30-day readmissions Health related QOL ED ≤3-days DES 60% ED, 62% LD
GP IIb/IIIa inhibitors 61.7% ED, 71.3% LD
Aspiration thrombectomy 48.6% ED, 55.6% LD
Radial access 50.5% ED, 66.7% LD
30-days ED ≤ 3 days
Events = 0
Total = 107
Risk Ratio ED = 0/107

LD > 3 days
Events = 0
Total = 108
Risk Ratio LD = 0/108
ED ≤ 3 days
Events = 4
Total = 107
Risk Ratio ED = 4/107

LD > 3 days
Events = 3,
Total = 108
Risk Ratio LD = 3/108
ED ≤ 3 days
Events = 1
Total = 107
Risk Ratio for ED = 1/107

LD > 3 days
Events = 3
Total = 108
Risk Ratio for ED = 3/108
Azzalini 2015 (EDAMI) 100
ED (54)
CDS (46)
PPC1 for STEMI within 12 h of onset, Zwolle risk score ≤ 3,symptoms Feasibility of ED vs LD Strategy ED ≤3-days BMS 42%
DES 56%
POBA 2%
Aspirin 99%
Clopidogrel 88%
Prasugrel 11%
Ticagrelor 1%
ED ≤ 3 days
Events = 0
Total = 54
LD > 3 days
Events = 0
Total = 46
Kotowycz 2010 (SAFE-DEPART) 54
ED (27)
LD (27)
PPCI or Rescue PCI for STEMI Feasibility of ED vs LD Strategy ED ≤ 2–3 days Aspirin
Clopidogrel
ED ≤ 3 days
Events = 2
Total = 27
Risk Ratio ED = 2/27

LD > 3 days Event = 1
Total = 27
Risk Ratio LD = 1/27
Jirmar 2008 (PRAGUE-5) 56
ED (37)
LD (19)
PPC1 for Uncomplicated STEMI
TIMI-3 flow with <20% residual stenosis
Single vessel disease
EF >40%
Age < 75
Feasibility and Safety of ED vs LD Strategy 30-day
Death
Reinfarction
Stroke
Unstable Angina
Rehospitalization
Repeat target vessel revascularization
Local groin complications
EF
ED ≤1 day Aspirin
Clopidogrel
30-days ED ≤ 1 day
Events = 1
Total = 37
Risk Ratio ED = 1/37

LD > 1 day
Events = 0
Total = 19
Risk Ratio LD = 0/19
Grines 1998 (PAMI-II) 471
ED (237)
LD (234)
PPCI for Low-risk STEMI
Age ≤70 years
LVEF >45%
≤ 2-Vessel disease
Successful PPCI
Composite of death, reinfarction, unstable ischemia, stroke or CHF by 6-months Death, reinfarction, unstable ischemia, stroke or CHF by 6-months ED ≤3 days Successful PTCA 96.1%
TIMI Grade 3 flow 92.9% vessels
6-months ED ≤ 3 days
Events = 2
Total = 237
Risk Ratio ED = 2/237

LD > 3 days
Events = 1
Total = 234
Risk Ratio LD = 1/234
ED ≤ 3 days
Events = 10,
Total = 237
Risk Ratio ED = 10/237

LD > 3 days
Events = 9,
Total = 234
Risk Ratio LD = 9/234
ED ≤ 3 days
Events = 36
Total = 237
Risk Ratio ED = 36/237

LD > 3 days
Events = 41
Total = 234
Risk Ratio LD = 41/234
Novobilsky 2018 151
ED (76)
LD (75)
PPCI STEMI ≤ 12 h after onset
Age ≤ 75 years
EF >45%
≤ 2-Vessel disease
Successful PPCI
No arrhythmias or hemodynamic instability >2 h after PPCI
Composite of death, MI, UA, stroke, unplanned rehospitalization, repeat target vessel revascularization, stent thrombosis at 90-days post discharge. ED ≤3 days DES 84.2% ED, 93.3% LD
GP IIb/IIIa inhibitors 14.5% ED, 16% LD
Aspiration thrombectomy 46.1% ED, 46.7% LD
Radial access 98.7% ED, 100% LD
ED ≤ 3 days
Events = 0
Total = 76
Risk Ratio ED = 0/76
LD > 3 days

Events = 0
Total = 75
Risk Ratio LD = 0/75
LD > 3 days
Events = 5
Total = 76
Risk Ratio ED = 5/76
LD > 3 days
Events = 6
Total = 75
Risk Ratio LD = 6/75

APN: Advanced practice nurse, BMS: Bare Metal Stent, CDS: Conventional discharge strategy, CHF: Congestive heart failure, D/C: Discharge, DES: Drug Eluting Stent, ED: Early discharge, EF: Ejection fraction, F/u: Follow up, GP: Glycoprotein, IQR: Interquartile range, LD: Late discharge, LOS: Length of stay, MACE: Major adverse cardiovascular events, MI: Myocardial infarction, NCDR: National cardiovascular disease registry, PPCI: Primary percutaneous coronary intervention, POBA: Percutaneous Old Balloon Angioplasty, QOL: Quality of life, STEMI: ST-Elevation myocardial infarction.